Ali F

No ORCID on file · 7 papers in corpus
observational 2026
F&S science ·doi:10.1016/j.xfss.2026.06.002

OBJECTIVE: To characterize the immune cell and hormonal profile of menstrual effluent compared with paired peripheral blood. DESIGN: This descriptive, cross-sectional study collected menstrual effluent and processed it to isolate cellular …

other 2025
Cureus ·doi:10.7759/cureus.c272

[This corrects the article DOI: 10.7759/cureus.38765.].

lab-animal 2024
BMC veterinary research ·doi:10.1186/s12917-024-03933-z

BACKGROUND: Saidi sheep are the most abundant ruminant livestock species in Upper Egypt, especially in the Assiut governorate. Sheep are one of the most abundant animals raised for food in Egypt. They can convert low-quality roughages into …

review 2023
Current epidemiology reports ·doi:10.1007/s40471-023-00332-0

PURPOSE OF REVIEW: a)The modifiable and non-modifiable determinants and the currently available methods of assessment of menstrual blood flow will be discussed, with the goal of helping healthcare providers, researchers, and those intereste…

other 2023
Cureus ·doi:10.7759/cureus.38765

Endometriosis is a benign gynecological condition that elicits chronic pain in 2-10% of reproductive-age women in the United States and exists in approximately 50% of women with infertility. It creates complications such as hemorrhage and u…

review 2023
Current epidemiology reports ·doi:10.1007/s40471-023-00333-z

PURPOSE OF REVIEW: Menstruation touches all spheres of human society, including psychology, education, business, policy, race, and religion. This narrative review aims to describe the relationship menstruation holds with these spaces. RECE…

nonrandomized-trial 2020
Clinical pharmacokinetics ·doi:10.1007/s40262-020-00921-y

BACKGROUND AND OBJECTIVE: Elagolix is an oral, non-peptide, gonadotropin-releasing hormone receptor antagonist. It is approved for the treatment of moderate-to-severe pain associated with endometriosis and is being investigated for the trea…